This title will be presented as highly practical information pn pharmaceutical antiplatelet and anticoagulation therapy, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series. Each volume is designed to be between 120 and 250 pages containing practical illustrations and designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.Guidelines suggest against using GCSa#39;s. Outpatients with cancer and no other ... enoxaparin [29a31] (Table 5.10). Rivaroxaban is currently approved for DVT prophylaxis in major orthopedic 192 C. Dittus and J. Ansell New Oral Anticoagulants.
|Title||:||Antiplatelet and Anticoagulation Therapy|
|Author||:||Albert Ferro, David A. Garcia|
|Publisher||:||Springer Science & Business Media - 2012-10-13|